Market Snapshot – Positive Momentum with Caution
Monster Beverage (MNST) is showing signs of technical strength with a score of 6.94, indicating a “neutral to trend” with 2 positive indicators and 0 bearish signals. The recent price trend is up 7.44%, aligning with a largely “Buy”-oriented analyst consensus.
News Highlights – Mixed Global Headwinds
- August 1, 2025 – New U.S. tariffs on food and beverages could impact Monster Beverage's market, with potential cost increases for popular products, according to the National Restaurant Association.
- August 6, 2025 – GTRI analyst Ajay Srivastava warned that the 25% additional tariffs on Indian goods could reduce exports to the U.S. by 40-50%, which may indirectly affect MNST's global beverage distribution channels.
- July 31, 2025 – Almarai announced the completion of its acquisition of Pure Beverages Industry Co, a move that could increase regional beverage production and indirectly create competitive pressure in the market.
Analyst Views & Fundamentals – Consensus Supports, Fundamentals Are Mixed
The simple average analyst rating score is 4.17, while the performance-weighted rating is 3.90, indicating a generally neutral to positive outlook. Rating dispersion is low, with 6 analysts issuing mostly “Buy” or “Strong Buy” ratings, and only one “Neutral” rating from
. This
alignment with the upward price trend suggests analysts are cautiously optimistic.
Key Fundamental Factors
- EV/EBIT = 52.10 (internal diagnostic score: 2): High valuation, but may indicate confidence in future earnings.
- PE = 73.17 (score: 1): High P/E suggests strong investor expectations, but may be a concern for value investors.
- Non-current liabilities / Total liabilities = 18.20% (score: 3): Suggests a relatively strong balance sheet.
- Total profit YoY growth = 8.45% (score: 2): Moderate growth, but not explosive.
- Basic EPS YoY growth = 14.29% (score: 1): Strong earnings growth, a positive sign.
- Net operating cash flow YoY growth = 14.75% (score: 1): Healthy cash generation.
- Long-term debt to working capital = 0.09% (score: 3): Extremely low leverage, a major strength.
- CFOA = 0.48% (score: 3): Strong cash flow from operations supports long-term health.
- Diluted EPS YoY growth = 14.46% (score: 1): Indicates strong profitability growth.
- Net profit attributable to shareholders YoY growth = 7.42% (score: 1): Suggests consistent profitability improvement.
Money-Flow Trends – Institutional and Retail Synergy
Monster Beverage is seeing positive inflows across all investor sizes. The fund-flow score is 7.86, indicating “good” performance. Notably:
- Extra-large inflow ratio = 60.77% – Institutional investors are showing strong confidence.
- Small and medium inflow ratios hover around 50% – Suggesting broad retail support.
- Large inflow ratio = 49.71% – Indicates some caution from mid-size investors.
Key Technical Signals – Overbought Conditions and Earnings Momentum
Monster Beverage is currently showing modestly bullish technicals, with an internal diagnostic score of 6.94, and 2 positive indicators and 0 bearish signals over the past 5 days.
Top Scoring Indicators (0-10 internal diagnostic scale):
- Williams %R Overbought – 7.24 (modestly bullish, historically shows a 64.79% win rate with an average return of 5.00%)
- Earnings Release Date – 7.60 (strongly bullish, with a 66.67% win rate and 22.00% average return)
Recent Chart Patterns (Past 5 Days):
- July 25 – Williams %R Overbought and MACD Golden Cross signals appeared.
- July 31 – Williams %R Oversold signal appeared, suggesting a potential bounce.
- August 7 – Earnings Release Date – the most bullish trigger recently.
Key Technical Insight:
The technical trend is “neutral to strong” with 2 positive signals and 0 bearish. Price is in an overbought zone, and the MACD Golden Cross suggests short-term upward momentum.
Conclusion – A Watchful Window for MNST
Monster Beverage is showing modest technical strength and positive institutional and retail flows, but fundamental growth remains moderate. The earnings release on August 7 could be a catalyst. With internal diagnostic scores ranging from 6.61 (fundamentals) to 6.94 (technical), the stock appears in a watchful window.
Actionable takeaway: Investors should consider holding or cautiously accumulating ahead of earnings, but monitor for overbought conditions to avoid a potential pullback.
Comments
No comments yet